Content area
Full Text
"There is new hope in the fight against cancer, thanks to the landmark research in cancer cell and gene therapy that is successfully treating and healing patients in clinical trials," said Barbara Netter, president and co-founder of the Stamford-based Alliance for Cancer Gene Therapy (ACGT).
"We're excited by the tangible results from the clinical trials ACGT has funded and the promise that this therapy holds as a viable treatment option for cancer patients." She added, "It is a means of targeting specific gene and cell mutations, thereby reducing or eliminating the side effects of traditional chemotherapy and radiation treatments."
As the nation's only not-for-profit exclusively dedicated to cancer cell and gene therapy treatments for all types of cancer, ACGT to date has awarded more than $24 million in grants to 42 prominent researchers in the U.S. and Canada.
"It's important to note that gene therapy was only an emerging field when we began," she said. "The innovative research, led by some of the most renowned scientific minds, has spurred tremendous progress toward eradicating cancer in a relatively short period of time."
Among the notable breakthrough clinical trials she cites...